News & Updates
Official announcements, product launches, and milestones from the WeDaita team.
The second Anthropic × Adaptyv protein design challenge - TNFa
Three design strategies. One challenging target. And a surprising lesson from nearly half our GPU compute.
Anthropic × Adaptyv Protein Design Competition
Super excited to be participating in the Anthropic × Adaptyv Protein Design Competition!
Read more
the First Anthropic × Adaptyv Protein Design Competition - EGFRa
After a week of work, many GPU hours, and several iterations refining our agentic AI workflow, we submitted …
Read moreWeDaita v2.12.0 is live
Chat now shows open agent questions, live activity, and research status in one panel, competitive landscape and Target …
Read moreWeDaita v2.11.0 is live
Virtual Cell Model, a new screening agent, is now live, Target Intelligence reports have a redesigned Target Profile …
Read moreWeDaita v2.10.0 is live
Macrocyclic peptide design is now fully live, you can cancel a running job instead of waiting it out, …
Read more
cyclic peptide binder design pipeline
Excited to share some recent results from our cyclic peptide binder design pipeline on the BioMedAI platform! 🧬✨
Read moreWeDaita v2.9.0 is live
A new Pro Preview trial lets you try premium features free, every research agent can now suggest what …
Read moreWeDaita v2.8.0 is live
Target Intelligence now predicts clinical progression across multiple indications, disease categories, and entire therapeutic areas instead of one …
Read moreWeDaita v2.7.0 is live
Target Intelligence now draws on a broader evidence base and applies disease-aware ranking to Target Prioritization, a new …
Read more
WeDaita has been awarded an additional $10,000 in AWS Credits
WeDaita has been awarded an additional $10,000 in AWS Credits through the AWS Startups program, following the initial …
Read more
WeDaita Inc. has been selected to present at the Plug and Play Health Tech Pitch Session
Excited to share that WeDaita Inc. has been selected to present at the Plug and Play Health Tech …
Read more